Countering 'the moral science of biopolitics
Understanding hepatitis C treatment 'non-compliance' in the antiviral era
Datos Bibliográficos
Although new hepatitis C treatments are a vast improvement on older, interferon-based regimens, there are those who have not taken up treatment, as well as those who have begun but not completed treatment. In this article, we analyse 50 interviews conducted for an Australian research project on treatment uptake. We draw on Berlant's (2007, Critical Inquiry, 33) work on 'slow death' to analyse so-called 'non-compliant' cases, that is, those who begin but do not complete treatment or who do not take antiviral treatment as directed. Approached from a biomedical perspective, such activity does not align with the neoliberal values of progress, self-improvement and rational accumulation that pervade health discourses. However, we argue that it is more illuminating to understand them as cases in which sovereignty and agency are neither simplistically individualised nor denied, and where 'modes of incoherence, distractedness, and habituation' are understood to co-exist alongside 'deliberate and deliberative activity [...] in the reproduction of predictable life' (Berlant, 2007, p. 754). The analysed accounts highlight multiple direct and indirect forces of attrition and powerfully demonstrate the socially produced character of agency, a capacity that takes shape through the constraining and exhausting dynamics of life in conditions of significant disadvantage
Agency (philosophy · Biopower · Compliance (psychology · Coronavirus disease 2019 (COVID-19 · Disadvantage · Disease · Environmental ethics · Pathology · Perspective (graphical · Political science · Politics · Social science · Sociology · Healthcare Systems and Challenges · Law · Medicine · Mental Health and Patient Involvement · Obesity and Health Practices · Philosophy · Psychology · Social Psychology
Hepatitis C treatment access and uptake for people who inject drugs
Complexities
Syndemics and the biosocial conception of health
It's not ‘just deprivation’
Deaths of Despair and the Future of Capitalism
Making sense of ‘side effects’
Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries
Caring and curing
Life projects
Managing expense and expectation in a treatment revolution
Exhausted practical sovereignty and lateral agency
Hard-to-reach
Conditionalising the unemployed
Beyond the bubble that is Robodebt
Understanding the Australian Aboriginal experience of collective, historical and intergenerational trauma
Assemblages of Health
The Experience of Interferon-Based Treatments for Hepatitis C Infection
Post-crisis imaginaries in the time of direct-acting antiviral hepatitis C treatment
Putting at risk what we know
Syndemics and Public Health
Hepatitis C cure as a 'gathering
Slow Death (Sovereignty, Obesity, Lateral Agency)
| Obras citantes distintas | 2 |
|---|---|
| Citas por año | 0,67 |
| Intervalo de citas | 2023 - 2024 (2) |
| Velocidad de citación | recent |
| Altamente citado | No |
| Tipos de cita | Neutras: 2 |